レポートナンバー 0000033207
レノックス・ガストー症候群治療の世界市場（2022-2026）
TechNavio
Global Lennox-Gastaut Syndrome Treatment Market 2022-2026
発刊日
2022/09/05
言語英語
体裁PDF/120ページ
レポート概要
本レポートは、レノックス・ガストー症候群（LGS）治療市場を分析します。
世界のレノックス・ガストー症候群治療市場は、予測期間中に約4.42 %のCAGRで推移し、2022年から2026年の間に6億8,475万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、LGSのリスク要因を持つ人口の増加、LGSに対する認知度の向上、希少疾病用医薬品の指定などによって牽引されています。
調査範囲
-
市場セグメント
➣ タイプ別
◇ 非外科的治療
◇ 外科的治療
➣ 地域別
◇ 北アメリカ
◇ アジア
◇ ヨーロッパ
◇ その他の地域
本調査では、今後数年間におけるレノックス・ガストー症候群治療市場の成長を牽引する主要因の一つとして、植物化学物質の導入を挙げています。また、外科的治療法の進歩や戦略的提携は、市場の大きな需要につながるでしょう。
TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。
本レポートは以下の分野をカバーしています。
- レノックス・ガストー症候群治療の市場規模
- レノックス・ガストー症候群治療の市場予測
- レノックス・ガストー症候群治療市場の業界分析
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なレノックス・ガストー症候群治療市場ベンダーの詳細な分析を提供します
-
調査企業
➣ Akron Children's Hospital
➣ Amneal Pharmaceuticals Inc.
➣ Aquestive Therapeutics Inc.
➣ Cedars-Sinai Health System
➣ Cision Ltd.
➣ Eisai Co. Ltd.
➣ Epilepsy Foundation
➣ GlaxoSmithKline Plc.
➣ Lupin Ltd.
➣ Sun Pharmaceutical Industries Ltd.
➣ Supernus Pharmaceuticals Inc.
➣ Teva Pharmaceutical Industries Ltd.
➣ UCB SA, Upsher Smith Laboratories LLC
➣ Viatris Inc.
➣ Johnson and Johnson
また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社について
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
レポート詳細
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Non-surgical treatment - Market size and forecast 2021-2026
Exhibit 28: Chart on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
5.4 Surgical treatment - Market size and forecast 2021-2026
Exhibit 32: Chart on Surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Surgical treatment - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Cedars-Sinai Health System
Exhibit 85: Cedars-Sinai Health System - Overview
Exhibit 86: Cedars-Sinai Health System - Business segments
Exhibit 87: Cedars-Sinai Health System - Key offerings
Exhibit 88: Cedars-Sinai Health System - Segment focus
10.4 Cision Ltd
Exhibit 89: Cision Ltd - Overview
Exhibit 90: Cision Ltd - Product / Service
Exhibit 91: Cision Ltd - Key offerings
10.5 Eisai Co. Ltd.
Exhibit 92: Eisai Co. Ltd. - Overview
Exhibit 93: Eisai Co. Ltd. - Business segments
Exhibit 94: Eisai Co. Ltd. - Key offerings
Exhibit 95: Eisai Co. Ltd. - Segment focus
10.6 Epilepsy Foundation
Exhibit 96: Epilepsy Foundation - Overview
Exhibit 97: Epilepsy Foundation - Product / Service
Exhibit 98: Epilepsy Foundation - Key offerings
10.7 GlaxoSmithKline Plc
Exhibit 99: GlaxoSmithKline Plc - Overview
Exhibit 100: GlaxoSmithKline Plc - Business segments
Exhibit 101: GlaxoSmithKline Plc - Key news
Exhibit 102: GlaxoSmithKline Plc - Key offerings
Exhibit 103: GlaxoSmithKline Plc - Segment focus
10.8 Johnson and Johnson
Exhibit 104: Johnson and Johnson - Overview
Exhibit 105: Johnson and Johnson - Business segments
Exhibit 106: Johnson and Johnson - Key news
Exhibit 107: Johnson and Johnson - Key offerings
Exhibit 108: Johnson and Johnson - Segment focus
10.9 Supernus Pharmaceuticals Inc.
Exhibit 109: Supernus Pharmaceuticals Inc. - Overview
Exhibit 110: Supernus Pharmaceuticals Inc. - Product / Service
Exhibit 111: Supernus Pharmaceuticals Inc. - Key offerings
10.10 Teva Pharmaceutical Industries Ltd.
Exhibit 112: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 113: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 114: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 115: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 116: Teva Pharmaceutical Industries Ltd. - Segment focus
10.11 UCB SA
Exhibit 117: UCB SA - Overview
Exhibit 118: UCB SA - Product / Service
Exhibit 119: UCB SA - Key offerings
10.12 Upsher Smith Laboratories LLC
Exhibit 120: Upsher Smith Laboratories LLC - Overview
Exhibit 121: Upsher Smith Laboratories LLC - Product / Service
Exhibit 122: Upsher Smith Laboratories LLC - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 125: Currency conversion rates for US$
11.4 Research methodology
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations
in the incidence rate
